Trial Details
COMPLETEDBasic Information
| Clinical ID | c4223 |
|---|---|
| Identifier | NCT00818272 |
| Trial Title | Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Remicade (infliximab) |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2002-12 |
|---|---|
| Primary Completion Date | 2010-12 |
| Completion Date | 2010-12 |